Evidence map›Paper›PMID 24848955›Full record

ArticleRadiology2014

Science to practice: percutaneous biopsies in the NIR future--will fluorescence guide the way?

Peter L Choyke

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Radiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Peter L ChoykeMolecular Imaging Program, National Cancer Institute National Institutes of Health 10 Center Dr, MSC 1182 Building 10, Room B3B69F Bethesda, MD 20892.

Funding

Prostate Cancer ImagingZIABC010655 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CHOYKE, PETER L · 2009 to 2025
$49.2M
Growth Factor Imaging and PhotoimmunotherapyZIABC010656 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CHOYKE, PETER L · 2009 to 2024
$31.6M
6 · The paper itself

Abstract

Sheth et al present a fascinating glimpse into the future of imaging-guided biopsies. Increasingly, such biopsies are being performed by fusing two or more modalities, such as computed tomography (CT) and ultrasonography (US). To this list should be added optical fluorescence guidance, which will complement all the advances hitherto developed for conventional imaging guidance. Similar progress is being made in the fields of endoscopy and surgery, and it is becoming clearer that optical fluorescence may light the path for many medical procedures in the "NIR," or near-infrared, future.

Indexed as

AnimalsBiopsyLiver Neoplasms, ExperimentalMolecular Imaging

Identifiers

PMID24848955
PMCPMC4263623

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.